A novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized treatment and reducing side effects.
The article from MSN discusses a groundbreaking development in gastric cancer research where scientists from the University of Cambridge have created a new 3D model of the stomach lining. This model, known as a gastric organoid, replicates the complex structure of the human stomach, providing a more accurate platform for studying gastric cancer. Traditional 2D cell cultures and animal models have limitations in mimicking human conditions, but this 3D model allows for better understanding of how cancer develops, progresses, and responds to treatments. The organoids are derived from human stem cells, which can be manipulated to simulate various stages of cancer development. This advancement not only enhances the study of gastric cancer but also has potential applications in personalized medicine, where treatments could be tailored based on the specific characteristics of a patient's tumor. The model's ability to closely mimic the human stomach environment could lead to more effective therapies and a deeper understanding of the disease's mechanisms.
Food & Wine 
